Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience

Brandt A, Vasova I, Winkler J, Mackensen A, Rösler W, Spoerl S, Völkl S (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 53-53

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Adrian Brandt Lehrstuhl für Arbeits-, Sozial- und Umweltmedizin Ingrid Vasova Lehrstuhl für Innere Medizin V Julia Winkler Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Wolf Rösler Department of Medicine 5 – Haematology and Oncology Simon Völkl Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Brandt, A., Vasova, I., Winkler, J., Mackensen, A., Rösler, W., Spoerl, S., & Völkl, S. (2020). Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience. In ONCOLOGY RESEARCH AND TREATMENT (pp. 53-53). BASEL: KARGER.

MLA:

Brandt, Adrian, et al. "Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 53-53.

BibTeX: Download